Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Propensity score matching was applied to compare tirzepatide (N=42,600) with non-GLP-1 anti-obesity medications (N=183,460)
The platform does not affect the results of prescribing and does not interfere with clinical judgment
Some companies also file additional patents for things like delivery methods or dosing schedules to extend exclusivity even further
Sources FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (FDA) FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S
Individual Tolerance: We always start cautiously and monitor your body's response
Social isolation is associated with increased mortality, disability, and dementia
US$ 28.10
US$ 27.98
US$ 22.74
US$ 22.91
US$ 26.24
US$ 25.52
US$ 24.72
US$ 22.13
